Skip to main content
Công ty Cổ phần Dược Hậu Giang logo

Công ty Cổ phần Dược Hậu Giang — Investor Relations & Filings

Ticker · DHG ISIN · VN000000DHG0 HSX Manufacturing
Open in API
Filings indexed 181 across all filing types
Latest filing 2025-01-22 Board/Management Inform…
Country VN Viet Nam
Listing HSX DHG

About Công ty Cổ phần Dược Hậu Giang

www.dhgpharma.com.vn

Công ty Cổ phần Dược Hậu Giang (DHG Pharma) is a leading pharmaceutical enterprise with over 50 years of experience. The company specializes in the research, development, manufacturing, and distribution of a diverse portfolio of pharmaceutical products, including both supportive and treatment medications. DHG Pharma emphasizes the application of high technology and international production standards to ensure product quality. Key brands include Telfor, Bocalex, Natto DHA, Hapacol, and Biofermin, serving a broad consumer base. Committed to public health, DHG Pharma actively engages in community health initiatives and strives to provide high-quality, accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
DHG: Thông báo thay đổi nhân sự công ty
Board/Management Information Classification · 95% confidence The document is a formal corporate notice addressed to the State Securities Commission and the Ho Chi Minh Stock Exchange announcing the resignation of a senior executive (Technical Director) and the Board of Directors’ resolution approving that change. This fits the definition of a Board/Management Information filing (announcement of changes in the company’s board or senior management).
2025-01-22 Vietnamese
DHG: Giải trình biến động kết quả kinh doanh quý 4/2024 so với quý 4/2023
Earnings Release Classification · 85% confidence The document is a short, regulatory-mandated disclosure of Q4/2024 and full year 2024 business results, presenting key financial highlights (net sales, PBT, PAT) and commentary. It is not a full interim report with complete financial statements, nor an AGM or voting notice, nor a management change or audit report. This format aligns with an Earnings Release (key highlights only). Q4 2024
2025-01-20 Vietnamese
DHG: Thông báo về ngày đăng ký cuối cùng tạm ứng cổ tức năm 2024 bằng tiền
Notice of Dividend Amount Classification · 95% confidence The document is an official notice from the Ho Chi Minh Stock Exchange announcing the record date and details for a cash dividend payment (40% of par value) by Công ty Cổ phần Dược Hậu Giang, including ex‐dividend date, record date, dividend rate, payment date, and procedures for shareholders. This matches the definition of a Notice of Dividend Amount.
2024-12-12 Vietnamese
DHG: Nghị quyết HĐQT về việc tạm ứng cổ tức năm 2024 bằng tiền mặt
Notice of Dividend Amount Classification · 89% confidence The document is an extraordinary information disclosure to the State Securities Commission and Ho Chi Minh Stock Exchange announcing a Board of Directors resolution to pay an advance cash dividend for 2024. It specifies the dividend rate, record date, and payment date. This fits the “Notice of Dividend Amount” category (DIV).
2024-12-09 Vietnamese
DHG: Thông báo nhận được Quyết định xử phạt vi phạm hành chính về thuế của Cục thuế tỉnh Cần Thơ
Legal Proceedings Report Classification · 95% confidence The document is an “Extraordinary Information Disclosure” by DHG Pharmaceutical JSC to the State Securities Commission and Ho Chi Minh Stock Exchange, detailing a tax authority decision imposing administrative penalties (tax shortfalls and fines). This is a regulatory enforcement action by a government body and constitutes an update on legal/regulatory proceedings. It is not a financial report, earnings release, management change, or dividend notice. Therefore, it falls under Legal Proceedings Report (LTR).
2024-12-04 Vietnamese
DHG: Thông báo thay đổi nhân sự - Tổng Giám đốc điều hành
Board/Management Information Classification · 95% confidence The document is a formal announcement to regulatory authorities (State Securities Commission and Ho Chi Minh Stock Exchange) and includes a Board of Directors resolution regarding the appointment of a new Chief Operating Officer (COO). It exclusively deals with changes in senior management personnel and contains a Board resolution text authorizing the appointment. This fits the definition of a Board/Management Information filing.
2024-11-29 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.